Wexford Capital »

Taysha Gene Therapies shares owned by Wexford Capital

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 3.5k 3.27

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Nephros (NEPH)
Core Natural Resources Com Shs (CNR)
EQT Corporation (EQT)
Chesapeake Energy Corp (EXE)
Energy Transfer Com Ut Ltd Ptn (ET)
Teekay Tankers Cl A (TNK)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Imperial Pete Com New (IMPP)
Acm Resh Com Cl A (ACMR)
Enterprise Products Partners (EPD)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Century Aluminum Company (CENX)
Antero Res (AR)

View all positions for Wexford Capital

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
Morgan Stanley
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings

View all funds holding Taysha Gene Therapies